Goetz MA, et al. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties. J. Antibiot. 38: 1633-1637, 1985. PubMed: 3005212
Ibrahim AR, Abul-Hajj YJ. Microbiological transformation of flavone and isoflavone. Xenobiotica 20: 363-373, 1990. PubMed: 2346033
Formisyn P, et al. Biotransformation by fungi: oxidation of ellipticine into 9-hydroxy-ellipticine by an Aspergillus alliaceus strain CBS 536.65. Lett. Appl. Microbiol. 19: 244-246, 1994.
Laakso JA, et al. Isokotanins A-C: new bicoumarins from the sclerotia of Aspergillus alliaceus. J. Nat. Prod. 57: 128-133, 1994. PubMed: 8158157
Chien MM, Rosazza JP. Microbial transformations of natural antitumor agents. VIII. Formation of 8- and 9-hydroxy-ellipticines. Drug Metab. Dispos. 7: 211-214, 1979. PubMed: 39722
Burkhead KD, et al. I. Hydroxylation of aniline by Aspergillus alliaceus, A. albertensis and A. terreus. J. Ind. Microbiol. 13: 233-237, 1994.
|
